{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:29:13Z","timestamp":1790623753411,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930004"],"award-info":[{"award-number":["81930004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82293630"],"award-info":[{"award-number":["82293630"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.canlet.2024.217158","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T23:47:17Z","timestamp":1722901637000},"page":"217158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells"],"prefix":"10.1016","volume":"600","author":[{"given":"Yu-Qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Peter","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ting","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.217158_bib1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni1080","article-title":"Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity","volume":"5","author":"Hope","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2024.217158_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature22993","article-title":"Tracing the origins of relapse in acute myeloid leukaemia to stem cells","volume":"547","author":"Shlush","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.217158_bib3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","article-title":"Biology and relevance of human acute myeloid leukemia stem cells","volume":"129","author":"Thomas","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.217158_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00277-010-1118-7","article-title":"Leukemia stem cells","volume":"90","author":"Testa","year":"2011","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.canlet.2024.217158_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.217158_bib6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.217158_bib7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI41495","article-title":"Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD\/SCID\/IL2R\u03b3c-deficient mice","volume":"121","author":"Sarry","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.217158_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2015.08.008","article-title":"CD93 marks a non-quiescent human leukemia stem cell population and is required for development of MLL-rearranged acute myeloid leukemia","volume":"17","author":"Iwasaki","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2024.217158_bib9","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2007-03-083048","article-title":"The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells","volume":"110","author":"van Rhenen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.217158_bib10","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"Jin","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.217158_bib11","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0704271104","article-title":"CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia","volume":"104","author":"Hosen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2024.217158_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.217158_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","article-title":"TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells","volume":"7","author":"Kikushige","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2024.217158_bib14","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.2415","article-title":"Stem cell gene expression programs influence clinical outcome in human leukemia","volume":"17","author":"Eppert","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.217158_bib15","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1182\/bloodadvances.2020001802","article-title":"CD200 expression marks leukemia stem cells in human AML","volume":"4","author":"Ho","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.canlet.2024.217158_bib16","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.canlet.2024.217158_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121314","article-title":"A mass spectrometric-derived cell surface protein atlas","volume":"10","author":"Bausch-Fluck","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.217158_bib18","doi-asserted-by":"crossref","first-page":"D1034","DOI":"10.1093\/nar\/gks1021","article-title":"HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis","volume":"41","author":"Bagger","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.canlet.2024.217158_bib19","doi-asserted-by":"crossref","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.canlet.2024.217158_bib20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1172\/JCI93198","article-title":"JAM3 maintains leukemia-initiating cell self-renewal through LRP5\/AKT\/\u03b2-catenin\/CCND1 signaling","volume":"128","author":"Zhang","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.217158_bib21","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1182\/bloodadvances.2020001802","article-title":"CD200 expression marks leukemia stem cells in human AML","volume":"4","author":"Ho","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.canlet.2024.217158_bib22","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/s41598-018-38408-3","article-title":"IL1RL1 is dynamically expressed on Cbfb-MYH11 leukemia stem cells and promotes cell survival","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2024.217158_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41467-020-20717-9","article-title":"Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells","volume":"12","author":"Larrue","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.217158_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2018.10.016","article-title":"IKZF2 drives leukemia stem cell self-renewal and inhibits myeloid differentiation","volume":"24","author":"Park","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2024.217158_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00007691-200002000-00010","article-title":"The FTY720 story","volume":"22","author":"Napoli","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.canlet.2024.217158_bib26","doi-asserted-by":"crossref","first-page":"23106","DOI":"10.18632\/oncotarget.7145","article-title":"The emerging role of FTY720 (Fingolimod) in cancer treatment","volume":"7","author":"White","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2024.217158_bib27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/sj.leu.2404131","article-title":"Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34+CD38- cells","volume":"20","author":"de Grouw","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2024.217158_bib28","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1158\/1078-0432.CCR-04-0212","article-title":"Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia","volume":"11","author":"Raaijmakers","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217158_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cyto.b.20403","article-title":"Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia","volume":"74","author":"de Figueiredo-Pontes","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.canlet.2024.217158_bib30","first-page":"1741","article-title":"The relationship between multi-drug resistance and proportion of leukemia stem cells and expression of drug transporters in drug-resistant leukemia K562\/ADM cells","volume":"89","author":"Yi","year":"2009","journal-title":"Zhonghua Yixue Zazhi"},{"key":"10.1016\/j.canlet.2024.217158_bib31","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1634\/stemcells.2004-0292","article-title":"Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples","volume":"23","author":"Pearce","year":"2005","journal-title":"Stem Cell."},{"key":"10.1016\/j.canlet.2024.217158_bib32","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-13-3456","article-title":"The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation","volume":"74","author":"Raha","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.217158_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.244","article-title":"MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis","volume":"8","author":"Musa","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.217158_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40291-019-00401-5","article-title":"S1PR1 as a novel promising therapeutic target in cancer therapy","volume":"23","author":"Rostami","year":"2019","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.canlet.2024.217158_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13046-017-0573-6","article-title":"Akt\/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma","volume":"36","author":"Zhang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.217158_bib36","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1021\/jm800295d","article-title":"The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer","volume":"51","author":"Folkes","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2024.217158_bib37","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.7150\/thno.25308","article-title":"Targeting S1PR1\/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine","volume":"8","author":"Lankadasari","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2024.217158_bib38","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.3892\/mmr.2016.5629","article-title":"S1PR1 mediates anti-apoptotic\/pro-proliferative processes in human acute myeloid leukemia cells","volume":"14","author":"Xu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2024.217158_bib39","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1084\/jem.20190598","article-title":"CD97 is a critical regulator of acute myeloid leukemia stem cell function","volume":"216","author":"Martin","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2024.217158_bib40","doi-asserted-by":"crossref","first-page":"17ra19","DOI":"10.1126\/scitranslmed.3000349","article-title":"Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells","volume":"2","author":"Saito","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2024.217158_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13287-021-02155-6","article-title":"CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia","volume":"12","author":"Liu","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.canlet.2024.217158_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41375-019-0522-9","article-title":"Targeting cell membrane HDM2: a novel therapeutic approach for acute myeloid leukemia","volume":"34","author":"Wang","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2024.217158_bib43","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1073\/pnas.1100551108","article-title":"Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker","volume":"108","author":"Jan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2024.217158_bib44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/2643-3230.BCD-20-0155","article-title":"Sphingosine-1-phosphate receptor 3 potentiates inflammatory programs in normal and leukemia stem cells to promote differentiation","volume":"2","author":"Xie","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.canlet.2024.217158_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113341","article-title":"Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases","volume":"153","author":"Chen","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524005536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524005536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:47:51Z","timestamp":1726620471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524005536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"alternative-id":["S0304383524005536"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217158","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217158"}}